Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > JDRF UK supports first-of-its-kind sex and gender policy for research
Most research is done on male cells, animals and individuals, which has led to gaps in the scientific evidence about how health and disease affect other sexes and/or genders. The UK currently has no standard, unified guidance for researchers about how to adequately consider sex in cell and animal studies, and sex and gender in human studies.
We are joining with other UK medical research organisations to address these gaps and improve the accuracy of scientific research through The George Institute for Global Health’s Medical Science Sex and Gender Equity (MESSAGE) project.
A person’s experience of health and disease can be conditioned by their biological attributes (their sex) and by their roles, behaviours and identity in society (their gender). Under the new sex and gender policy, research involving cells and animals will be concerned only with sex. Research involving humans may be concerned with the sex of its participants or with their gender, or both, depending on the research topic.
Sex and gender play fundamental roles in individual and population health. They influence the medical conditions people develop, the symptoms they experience, the treatments and quality of care they receive, their disease progression and their overall outcomes. Studying and understanding sex and gender differences and similarities is essential for ensuring the safety and effectiveness of medicines and care, to improve the health of all people in the UK.
Research that doesn’t account for sex and gender produces results that are less accurate and reproducible and bring benefit to a smaller proportion of society. Sex and gender inclusive research leads to more targeted care and better outcomes for all people, particularly for cis women, trans, non-binary and intersex people and people with variations of sex characteristics.
We currently provide our research community with guidance on ensuring their research proposals consider the needs of all people with type 1 diabetes, no matter their sex or gender or other characteristics. We are issuing a Statement of Intent for the MESSAGE initiative, committing to providing the research community with further guidance and tools to ensure type 1 diabetes research is fully representative of all the people who live with this condition.
The MESSAGE policy framework, training materials for researchers and funding organisations about how to integrate sex and gender in your work will be launched in 2024. They will include further resources including an annotated bibliography to help researchers understand sex and gender dimensions identified in previous research.
Visit the section of our website for researchers including our funding opportunities and how to apply.
Discover the type 1 diabetes research projects we are currently funding in the UK.
Donate now to help fund our groundbreaking type 1 diabetes research.
You may have heard of a new feature called ‘CamAPS Liberty’, which will soon be available on the CamAPS FX app. This ‘fully closed-loop’ (FCL) mode, when activated; will allow users to remove the need to count carbohydrates before a meal. But what does this mean for people with type 1 diabetes (T1D), and how close are we to removing meal announcement altogether? Here is what we know…
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
